SCHEMBL14834641

SCHEMBL14834641

Cc1cccc(CCCBr)n1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KCNH2 Q12809 3/20 0.47
SMN1; SMN2 Q16637 1/20 0.42
CCR1 P32246 1/20 0.41
CCR8 P51685 1/20 0.41
NOS2 P35228 2/20 0.39
NOS3 P29474 1/20 0.39
NOS1 P29475 1/20 0.37
HSD17B3 P37058 1/20 0.37
KDM1A O60341 1/20 0.36
MAOA P21397 1/20 0.36
MAOB P27338 1/20 0.36
MEN1 O00255 1/20 0.36
OPRM1 P35372 1/20 0.36
OPRD1 P41143 1/20 0.36
KMT2A Q03164 1/20 0.36
GABRA1 P14867 1/20 0.35
GABRG2 P18507 1/20 0.35
GABRB3 P28472 1/20 0.35
GABRA5 P31644 1/20 0.35
GABRA3 P34903 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27265753 0.88 SMN1; SMN2 (0.45) KCNH2SMN1; SMN2CCR1CCR8NOS2
Bromide SCHEMBL9937840 0.86 SMN1; SMN2 (0.44) KCNH2SMN1; SMN2CCR1CCR8NOS2
SCHEMBL5155 0.83
SCHEMBL29419394 0.83
SCHEMBL24916774 0.83 CCR1 (0.52) KCNH2SMN1; SMN2CCR1CCR8NOS2
SCHEMBL30201993 0.83 CCR1 (0.52) KCNH2SMN1; SMN2CCR1CCR8NOS2
SCHEMBL681574 0.82 KCNH2 (0.64) KCNH2SMN1; SMN2CCR1CCR8NOS2
Bromide SCHEMBL11282133 0.81 CCR1 (0.46) KCNH2SMN1; SMN2CCR1CCR8NOS2
SCHEMBL10144469 0.81 KCNH2 (0.54) KCNH2SMN1; SMN2CCR1CCR8NOS2
SCHEMBL10416918 0.80 KCNH2 (0.38) KCNH2SMN1; SMN2CCR1CCR8HSD17B3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2576510-A1 PIPERIDINONE DERIVATIVES AS MDM2 INHIBITORS FOR THE TREATMENT OF CANCER Amgen Inc. (US) 2013-04-10 EP disclosed
WO-2011153509-A1 PIPERIDINONE DERIVATIVES AS MDM2 INHIBITORS FOR THE TREATMENT OF CANCER AMGEN INC. (US) 2011-12-08 WO disclosed